When doctors chat with patients eye to eye, it’s not just about creating rapport. Certain facial traits may reveal vital ...

Eczema is a chronic skin condition that shares similarities with autoimmune skin conditions, but it’s not an autoimmune ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

After posting a phase 3 eczema trial win in January ... The FDA is expected to issue its verdict on the drug in atopic ...

Almirall has rolled out a new campaign for World Atopic Eczema Day, kicking off its “The T | Almirall has rolled out a new ...

Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, ...

The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...

Increasing clinical evidence links changes in the composition of the gut microbiome to the development of various skin diseases such as eczema.

Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and ...

Allied Market Research published a report, titled, "Triamcinolone Market by Type (Cream, Injection and Inhalers), Application (Eczema, Dermatitis, Allergies, Psoriasis and Others), and Distribution ...

VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an ...

The FDA has approved lebrikizumab (Ebglyss; Eli Lilly) as a new first-line biologic treatment for patients aged 12 and older ...